131 related articles for article (PubMed ID: 16530070)
1. Chemoprevention of bladder cancer.
Grossman HB
Urology; 2006 Mar; 67(3 Suppl 1):19-22; discussion 23-4. PubMed ID: 16530070
[TBL] [Abstract][Full Text] [Related]
2. Retinoids in the prevention of bladder cancer.
Nutting CM; Huddart RA
Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of superficial bladder cancer.
Kamat AM
Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
[TBL] [Abstract][Full Text] [Related]
4. Bladder cancer clinical trials.
Lerner SP
Urol Oncol; 2005; 23(4):275-9. PubMed ID: 16018944
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention for bladder cancer.
Busby JE; Kamat AM
J Urol; 2006 Nov; 176(5):1914-20. PubMed ID: 17070211
[TBL] [Abstract][Full Text] [Related]
6. Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer.
Hendricksen K; Witjes JA
Curr Opin Urol; 2007 Sep; 17(5):352-7. PubMed ID: 17762630
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of superficial bladder cancer.
Gee J; Sabichi AL; Grossman HB
Crit Rev Oncol Hematol; 2002 Sep; 43(3):277-86. PubMed ID: 12270783
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
Grossman HB; Stenzl A; Moyad MA; Droller MJ
Scand J Urol Nephrol Suppl; 2008 Sep; (218):213-33. PubMed ID: 18815935
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
10. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
[TBL] [Abstract][Full Text] [Related]
11. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
Sabichi AL; Lerner SP; Atkinson EN; Grossman HB; Caraway NP; Dinney CP; Penson DF; Matin S; Kamat A; Pisters LL; Lin DW; Katz RL; Brenner DE; Hemstreet GP; Wargo M; Bleyer A; Sanders WH; Clifford JL; Parnes HL; Lippman SM
Clin Cancer Res; 2008 Jan; 14(1):224-9. PubMed ID: 18172274
[TBL] [Abstract][Full Text] [Related]
12. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
[TBL] [Abstract][Full Text] [Related]
13. Potential chemoprevention effect of dietary fucoxanthin on urinary bladder cancer EJ-1 cell line.
Zhang Z; Zhang P; Hamada M; Takahashi S; Xing G; Liu J; Sugiura N
Oncol Rep; 2008 Nov; 20(5):1099-103. PubMed ID: 18949407
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of bladder cancer.
La Rochelle J; Kamat A; Grossman HB; Pantuck A
BJU Int; 2008 Nov; 102(9 Pt B):1274-8. PubMed ID: 19035892
[No Abstract] [Full Text] [Related]
15. Bladder preserving strategies for muscle-invasive bladder cancer.
Merseburger AS; Matuschek I; Kuczyk MA
Curr Opin Urol; 2008 Sep; 18(5):513-8. PubMed ID: 18670277
[TBL] [Abstract][Full Text] [Related]
16. Urological implications of concurrent bladder and lung cancer.
Vainrib M; Leibovitch I
Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
18. Use of selenium in chemoprevention of bladder cancer.
Brinkman M; Buntinx F; Muls E; Zeegers MP
Lancet Oncol; 2006 Sep; 7(9):766-74. PubMed ID: 16945772
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
20. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
